Midcourse Review  >  Table of Contents  > Focus Area 14: Immunization and Infectious Diseases  >  Disparities Table

Figure 14-2. Disparities Table for Focus Area 14: Immunization and Infectious Diseases
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from the baseline to the most recent data point.

Race and Ethnicity  |  Gender and Education  |  Income, Location, and Disability


Characteristics: Race and Ethnicity
Population-based objectives American Indian or Alaska Native Asian Native Hawaiian
or other
Pacific Islander		 Two or more races Hispanic or Latino Black non-Hispanic White non-Hispanic Summary index
14-3a. Hepatitis B: 19-24 years (1997, 2003)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. Increase in disparity 10-49 percentage points (50-99 percent difference from the best group rate) Decrease in disparity 100 or more percentage points (50-99 percent difference from the best group rate). Data are for Asians or Pacific Islanders. Decrease in disparity 100 or more percentage points (50-99 percent difference from the best group rate). Data are for Asians or Pacific Islanders. Data not available.The group with the best rate for specified characteristic. Decrease in disparity 10-49 percentage points (100 percent or more percent difference from the best group rate) 50-99 percent difference from the best group rate Decrease in disparity 50-99 percentage points (100 or more percent difference from the best group rate)
14-3b. Hepatitis B: 25-39 years (1997, 2003)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. Increase in disparity 10-49 percentage points (100 percent or more percent difference from the best group rate) Decrease in disparity 100 or more percentage points (10-49 percent difference from the best group rate). Data are for Asians or Pacific Islanders. Decrease in disparity 100 or more percentage points (10-49 percent difference from the best group rate). Data are for Asians or Pacific Islanders. Data not available.The group with the best rate for specified characteristic. Increase in disparity 50-99 percentage points (100 percent or more percent difference from the best group rate) 10-49 percent difference from the best group rate Decrease in disparity 10-49 percentage points (100 percent or more percent difference from the best group rate)
14-3c. Hepatitis B: 40+ years (1997, 2003)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. Increase in disparity 100 or more percentage points (100 percent or more percent difference from the best group rate) Decrease in disparity 100 or more percentage points (10-49 percent difference from the best group rate). Data are for Asians or Pacific Islanders. Decrease in disparity 100 or more percentage points (10-49 percent difference from the best group rate). Data are for Asians or Pacific Islanders. Data not available.Decrease in disparity 100 or more percentage points (10-49 percent difference from the best group rate) Decrease in disparity 50-99 percentage points (100 or more percent difference from the best group rate) The group with the best rate for specified characteristic. Decrease in disparity 50-99 percentage points (100 or more percent difference from the best group rate)
14-4. Bacterial meningitis: 1-23 months
(1998, 2003)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. 		Data not available.Data not available.Data not available.Data not available.Data not available.Increase in disparity 10-49 percentage points (100 percent or more percent difference from the best group rate). Data include persons of Hispanic origin. The group with the best rate for specified characteristic. Data include persons of Hispanic origin. Data not available.
14-5a. Invasive pneumococcal infections: < 5 years (1997, 2002)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. Data not available.Data not available.Data not available.Data not available.Less than 10 percent difference from the best group rate or not statistically significantDecrease in disparity 100 or more percentage points (50-99 percent difference from the best group rate). Data include persons of Hispanic origin. The group with the best rate for specified characteristic. Data include persons of Hispanic origin. 10-49 percent difference from the best group rate
14-5b. Invasive pneumococcal infections: 65+ years (1997, 2002)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. Data not available.Data not available.Data not available.Data not available.The group with the best rate for specified characteristic. Increase in disparity 50-99 percentage points (50-99 percent difference from the best group rate). Data include persons of Hispanic origin. 10-49 percent difference from the best group rate. Data include persons of Hispanic origin. 50-99 percent difference from the best group rate
14-5c. Invasive penicillin-resistant pneumococcal infections: < 5 years
(1997, 2002)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. 		Data not available.Data not available.Data not available.Data not available.10-49 percent difference from the best group rateIncrease in disparity 50-99 percentage points (100 percent or more percent difference from the best group rate). Data include persons of Hispanic origin. The group with the best rate for specified characteristic. Data include persons of Hispanic origin. 50-99 percent difference from the best group rate
14-5d. Invasive penicillin-resistant pneumococcal infections: 65+ years
(1997, 2002)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. 		Data not available.Data not available.Data not available.Data not available.The group with the best rate for specified characteristic. 10-49 percent difference from the best group rate. Data include persons of Hispanic origin. 10-49 percent difference from the best group rate. Data include persons of Hispanic origin. 10-49 percent difference from the best group rate
14-6. Hepatitis A (1997, 2003)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. The group with the best rate for specified characteristic: Decrease in disparity 100 or more percentage points. Disparity declined substantially for American Indians or Alaska Natives relative to Asians or Pacific Islanders, the group with the best rate at baseline. 50-99 percent difference from the best group rate. Data are for Asians or Pacific Islanders. 50-99 percent difference from the best group rate. Data are for Asians or Pacific Islanders. Data not available. Decrease in disparity 100 or more percentage points (100 percent or more percent difference from the best group rate) Decrease in disparity 10-49 percentage points (10-49 percent difference from the best group rate) Decrease in disparity 10-49 percentage points (10-49 percent difference from the best group rate) Decrease in disparity 100 or more percentage points (50-99 percent difference from the best group rate).
14-7. Meningococcal disease (1997, 2002)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. Data not available.Data not available.Data not available.Data not available.Data not available.Data not available.Data not available.Data not available.
14-8. Lyme disease (1992-96, 2002)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. Data not available.Data not available.Data not available.Data not available.Data not available.Data not available.Data not available.Data not available.
14-9. Hepatitis C (1997, 2003)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. Data not available. Data not available. Data not available. Data not available. Data not available. Data not available. Best group rate reliability criterion not met. Data include persons of Hispanic origin. Data not available.
14-11. Tuberculosis (1998, 2003)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. 100 percent or more percent difference from the best group rate100 percent or more percent difference from the best group rate100 percent or more percent difference from the best group rateData not available. Increase in disparity 100 or more percentage points (100 percent or more percent difference from the best group rate) Increase in disparity 50-99 percentage points (100 percent or more percent difference from the best group rate) The group with the best rate for specified characteristic. 100 percent or more percent difference from the best group rate
14-12. Curative therapy for tuberculosis
(1996, 2000)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. 		The group with the best rate for specified characteristic. Increase in disparity 10-49 percentage points (50-99 percent difference from the best group rate). Data are for Asians or Pacific Islanders. Increase in disparity 10-49 percentage points (50-99 percent difference from the best group rate). Data are for Asians or Pacific Islanders. Data not available.10-49 percent difference from the best group rate Decrease in disparity 10-49 percentage points (10-49 percent difference from the best group rate) 10-49 percent difference from the best group rate10-49 percent difference from the best group rate
14-16. Invasive early onset group B streptococcal disease (1996, 2002)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. Data not available.Data not available.Data not available.Data not available.Data not available.Increase in disparity 100 or more percentage points (100 percent or more percent difference from the best group rate). Data include persons of Hispanic origin. The group with the best rate for specified characteristic. Data include persons of Hispanic origin. Data not available.
14-17. Peptic ulcer hospitalizations
(1998, 2001)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix. 		Data not available.Data not available.Data not available.Data not available.Data not available.10-49 percent difference from the best group rate. Data include persons of Hispanic origin. The group with the best rate for specified characteristic. Data include persons of Hispanic origin. Data not available.
14-18. Antibiotics prescribed for ear infections: < 5 years (1996-97, 2002-03)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix. Data not available.Data not available.Data not available.Data not available.Data not available.The group with the best rate for specified characteristic. Data include persons of Hispanic origin. 10-49 percent difference from the best group rate. Data include persons of Hispanic origin. Data not available.
14-19. Antibiotics prescribed for the common cold (1996-97, 2002-03)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix. Best group rate reliability criterion not met. Data not available.Data not available.Data not available.Data not available.Data not available.Best group rate reliability criterion not met. Data include persons of Hispanic origin. Data not available.Data not available.
14-22a. DTaP immunization: 4 doses, 19-35 months (1998, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Median ZIP code income levels: $25,000 or less, $25,001-$35,000, and more than $35,000. 10-49 percent difference from the best group rateMost favorable group rate for specified characteristic, but reliability criterion not met. Less than 10 percent difference from the best group rate or not statistically significant10-49 percent difference from the best group rate10-49 percent difference from the best group rate50-99 percent difference from the best group rateThe group with the best rate for specified characteristic. 10-49 percent difference from the best group rate
14-22b. Haemophilus influenzae type B immunization: 3 doses, 19-35 months
(1998, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Median ZIP code income levels: $25,000 or less, $25,001-$35,000, and more than $35,000.		 Less than 10 percent difference from the best group rate or not statistically significant50-99 percent difference from the best group rateData not available.Less than 10 percent difference from the best group rate or not statistically significant10-49 percent difference from the best group rate50-99 percent difference from the best group rateThe group with the best rate for specified characteristic. 50-99 percent difference from the best group rate
14-22c. Hepatitis B immunization: 3 doses, 19-35 months (1998, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Median ZIP code income levels: $25,000 or less, $25,001-$35,000, and more than $35,000. Less than 10 percent difference from the best group rate or not statistically significantLess than 10 percent difference from the best group rate or not statistically significantData not available.Less than 10 percent difference from the best group rate or not statistically significant10-49 percent difference from the best group rateLess than 10 percent difference from the best group rate or not statistically significantThe group with the best rate for specified characteristic. Less than 10 percent difference from the best group rate or not statistically significant
14-22d. MMR immunization: 1 dose, 19-35 months (1998, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Median ZIP code income levels: $25,000 or less, $25,001-$35,000, and more than $35,000. Less than 10 percent difference from the best group rate or not statistically significantMost favorable group rate for specified characteristic, but reliability criterion not met. Data not available.10-49 percent difference from the best group rateLess than 10 percent difference from the best group rate or not statistically significantLess than 10 percent difference from the best group rate or not statistically significantThe group with the best rate for specified characteristic. Less than 10 percent difference from the best group rate or not statistically significant
14-22e. Polio immunization: 3 doses, 19-35 months (1998, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Median ZIP code income levels: $25,000 or less, $25,001-$35,000, and more than $35,000. Data not available.Less than 10 percent difference from the best group rate or not statistically significantData not available.10-49 percent difference from the best group rate10-49 percent difference from the best group rate50-99 percent difference from the best group rateThe group with the best rate for specified characteristic. 10-49 percent difference from the best group rate
14-22f. Varicella immunization: 1 dose, 19-35 months (1998, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Median ZIP code income levels: $25,000 or less, $25,001-$35,000, and more than $35,000. Less than 10 percent difference from the best group rate or not statistically significantMost favorable group rate for specified characteristic, but reliability criterion not met. 50-99 percent difference from the best group rateLess than 10 percent difference from the best group rate or not statistically significantThe group with the best rate for specified characteristic. Decrease in disparity 10-49 percentage points (less than 10 percent from the best group rate or not statistically significant). Decrease in disparity 10-49 percentage points (10-49 percent difference from the best group rate) Less than 10 percent difference from the best group rate or not statistically significant
14-22g. PCV immunization: 4 doses, 19-35 months (2002, 2003)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. Increase in disparity 10-49 percentage points (10-49 percent difference from the best group rate). The group with the best rate for specified characteristic. Data not available.10-49 percent difference from the best group rateData not available. Increase in disparity 10-49 percentage points (10-49 percent difference from the best group rate). 10-49 percent difference from the best group rate10-49 percent difference from the best group rate
14-24a. Fully immunized children: 19-35 months (1998, 2002)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Baseline data by race and ethnicity are for 2001. 50-99 percent difference from the best group rateMost favorable group rate for specified characteristic, but reliability criterion not met. Data not available.10-49 percent difference from the best group rate10-49 percent difference from the best group rate10-49 percent difference from the best group rateThe group with the best rate for specified characteristic. 10-49 percent difference from the best group rate
14-27a. Hepatitis B immunization: 3+ doses, 13-15 years (1997, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Baseline data by race and ethnicity are for 1999. Data not available.Data not available.Data not available.Data not available.Best group rate reliability criterion not met.Best group rate reliability criterion not met.Best group rate reliability criterion not met.Data not available.
14-27b. MMR immunization: 2+ doses, 13-15 years (1997, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Baseline data by race and ethnicity are for 1999. Data not available.Data not available.Data not available.Data not available.Best group rate reliability criterion not met.Best group rate reliability criterion not met.Best group rate reliability criterion not met.Data not available.
14-27c. Tetanus-diphtheria booster: 1+ dose(s), 13-15 years (1997, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Baseline data by race and ethnicity are for 1999. Data not available.Data not available.Data not available.Data not available.Best group rate reliability criterion not met.Best group rate reliability criterion not met.Best group rate reliability criterion not met.Data not available.
14-27d. Varicella immunization: 1+ dose(s), 13-15 years (1997, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Baseline data by race and ethnicity are for 1999. Data not available.Data not available.Data not available.Data not available.Best group rate reliability criterion not met.Best group rate reliability criterion not met.Best group rate reliability criterion not met.Data not available.
14-29a. Influenza vaccination in past year: noninstitutionalized, 65+ years (1998, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Baseline data by race and ethnicity are for 1999. Data not available.Less than 10 percent difference from the best group rate or not statistically significantData not available.Data not available. Increase in disparity 10-49 percentage points (50-99 percent difference from the best group rate) 50-99 percent difference from the best group rateThe group with the best rate for specified characteristic. 50-99 percent difference from the best group rate
14-29b. Pneumococcal vaccination ever received: noninstitutionalized, 65+ years
(1998, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Baseline data by race and ethnicity are for 1999.		 Data not available.50-99 percent difference from the best group rateData not available.Data not available.50-99 percent difference from the best group rate50-99 percent difference from the best group rateThe group with the best rate for specified characteristic. Increase in disparity 10-49 percentage points (50-99 percent difference from the best group rate)
14-29c. Influenza vaccination in past year: noninstitutionalized high-risk, 18-64 years (1998, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Baseline data by race and ethnicity are for 1999. Less than 10 percent difference from the best group rate or not statistically significantLess than 10 percent difference from the best group rate or not statistically significantData not available.The group with the best rate for specified characteristic. 10-49 percent difference from the best group rateLess than 10 percent difference from the best group rate or not statistically significantLess than 10 percent difference from the best group rate or not statistically significantLess than 10 percent difference from the best group rate or not statistically significant
14-29d. Pneumococcal vaccination ever received: noninstitutionalized high-risk, 18-64 years (1998, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix. Baseline data by race and ethnicity are for 1999. Data not available.Data not available.Data not available.Less than 10 percent difference from the best group rate or not statistically significant10-49 percent difference from the best group rateThe group with the best rate for specified characteristic. Less than 10 percent difference from the best group rate or not statistically significantLess than 10 percent difference from the best group rate or not statistically significant
14-29e. Influenza vaccination in past year: institutionalized, 18+ years (1997, 1999)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. Data not available.Data not available.Data not available.Data not available.Less than 10 percent difference from the best group rate or not statistically significantLess than 10 percent difference from the best group rate or not statistically significantThe group with the best rate for specified characteristic. Less than 10 percent difference from the best group rate or not statistically significant
14-29f. Pneumococcal vaccination ever received: institutionalized, 18+ years
(1997, 1999)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix.		 Data not available.Data not available.Data not available.Data not available.Less than 10 percent difference from the best group rate or not statistically significant Increase in disparity 10-49 percentage points (10-49 percent difference from the best group rate). The group with the best rate for specified characteristic. Less than 10 percent difference from the best group rate or not statistically significant
14-29g. Influenza vaccination in past 12 months: health care workers, 18-64 years (2000)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. Data not available.Data not available.Data not available.Data not available.10-49 percent difference from the best group rate10-49 percent difference from the best group rateThe group with the best rate for specified characteristic. 10-49 percent difference from the best group rate

Notes:

Data for objectives 14-1a through k, 14-2, 14-3d through g, 14-10, 14-13, 14-14, 14-20a through e, 14-21, 14-22h, 14-23a through k, 14-24b, 14-25a and b, 14-26, 14-28a, b, and c, 14-30a and b, and 14-31a and b are unavailable or not applicable. Objective 14-15 was deleted at the midcourse.

Years in parentheses represent the baseline data year and the most recent data year (if available).

Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (for example, race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the summary index at the most recent data point. See Technical Appendix for more information.


The best group rate at the most recent data point. The group with the best rate for specified characteristic. The group with
the best rate
for specified characteristic.		 Most favorable group rate for specified characteristic, but reliability criterion not met. Most favorable group rate for specified characteristic, but reliability criterion not met. Best group rate reliability criterion not met. Best group rate reliability criterion not met.    
 
Percent difference from the best group rate
Disparity from the best group rate at the most recent data point. Less than 10 percent difference from the best group rate or not statistically significant Less than 10 percent or not statistically significant 10-49 percent difference from the best group rate 10-49 percent 50-99 percent difference from the best group rate 50-99 percent 100 percent or more percent difference from the best group rate 100 percent or more
   
Increase in disparity (percentage points)
Changes in disparity over time are shown when the change is greater than or equal to 10 percentage points and statistically significant, or when the change is greater than or equal to 10 percentage points and estimates of variability were not available. Increase in disparity: 10-49 percentage points 10-49 Increase in disparity: 50-99 percentage points 50-99 Increase in disparity: 100 or more percentage points 100 or more
 
Decrease in disparity (percentage points)
Decrease in disparity: 10-49 percentage points 10-49 Decrease in disparity: 50-99 percentage points 50-99 Decrease in disparity: 100 or more percentage points 100 or more
Availability of data. Data not available. Data not available. Characteristic not selected for this objective. Characteristic not selected for this objective.

* The variability of best group rates was assessed, and disparities of ≥ 10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.
† Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix.
1 Data are for Asians or Pacific Islanders.
2 Data include persons of Hispanic origin.
3 Disparity declined substantially for American Indians or Alaska Natives relative to Asians or Pacific Islanders, the group with the best rate at baseline.
4 Baseline data by race and ethnicity are for 2000.
5 Baseline data by race and ethnicity are for 2001.
6 Baseline data only.
7 Baseline data by race and ethnicity are for 1999.

<<  Previous—Progress Quotient Chart    |   Table of Contents   |   Next—Disparities Table: Gender and Education  >>


[ Top ]